Board Of Directors

WORK EXPERIENCE

Mr. Ho is the Executive Chairman of Keck Seng (Malaysia) Berhad since 1970 and also of Keck Seng Investments (Hong Kong) Limited since 1979. He was previously a Non-Executive Director of Shangri-la Asia Limited since 1993 and a member of its Audit Committee. He was previously the Director of Parkway Holdings Limited/Parkway Pantai Limited from 1985 to 2013 and was the Chairman of the Tender Committee.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Business Administration and Commerce

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Executive Chairman of Keck Seng Investments (Hong Kong) Limited
• Executive Chairman of Keck Seng (Malaysia) Berhad

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Non-Executive Director of Shangri-la Asia Limited

WORK EXPERIENCE

Ms Goh is the Founding Director of 360 Dynamics since 1998. It is a boutique firm which provides consulting services to businesses on their organisational design and developmental needs. She guides corporate leaders to be more effective through an innate understanding of Organizational and leadership Dynamics. Her work covers the broader context of achieving business and societal objectives in an interconnected ecosystem that faces rapid changes. She was a Board member of the Agency for Integrated Care from 2012 to 2024.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• MSC, Organisational Psychology, City University of New York (Baruch College)
• BBA, National University of Singapore
• Senior Accredited Director, Singapore Institute of Directors

PRESENT DIRECTORSHIPS AND MAJOR APPOINTMENTS

• Board Member of Parkway Trust Management Limited
• Appointed Chairperson of Charity Council, Singapore

PAST DIRECTORSHIP

• Chairperson of SATA CommHealth Limited

WORK EXPERIENCE

Ms. Cheah serves as Executive Board Chair of privately held ESG startup ecoSPIRITS and sits on the boards of several publicly-listed companies in Singapore. She is also Venture Operating Partner at Wavemaker Partners, a tech-focused venture capital fund dual headquartered in Singapore and Los Angeles.

She previously spent more than 20 years in the investment banking industry. She started her career with Merrill Lynch New York, followed by stints in Singapore and London. Subsequently, she became Executive Director of Investment Banking at JP Morgan Singapore and later served as Co-head of Corporate Finance SEA at BNP Paribas.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• BA, Economics and French, Wellesley College, Massachusetts, USA
• Execuvite MBA (ongoing), Tsinghua University, PRC

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Executive Board Chair, ecoSPIRITS Pte Ltd
• Independent Non-Executive Director of Pathology Asia Holdings Pte Ltd ( also Chairman of Audit Committee)
• Independent Non-Executive Director of TeleChoice International Limited (also Member of Audit Committee)
• Independent Non-Executive Director of M&C REIT Management Limited (also Member of Nominating and Remuneration Committee)
• Independent Non-Executive Director of M&C Business Trust Management Limited
• Venture Partner of Wavemaker Partners

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• NIL

WORK EXPERIENCE

Mr. Tomo Nagahiro was appointed to the Board of IHH in February 2023. He was an alternate director on the Board of IHH from April 2019 to January 2023. Mr. Nagahiro has been appointed as Co-CEO and Director of MBK Healthcare Management Pte. Ltd., a wholly-owned subsidiary of Mitsui & Co., Ltd (Mitsui) since January 2024. He has over 20 years of working experience having served in multiple divisions in Mitsui, spanning from strategic planning, business development and operations management. Preceding his current appointment, he was seconded to MIMS Pte Ltd which is based in Singapore as the Chief Operating Officer from 2015 to 2018.

Prior to this, he was seconded to Parkway Pantai Limited, a wholly-owned subsidiary of IHH, as Assistant Vice President of Strategic Planning and Business Development where he led multiple business development projects from 2013 to 2015.

Mr. Nagahiro holds Bachelor of Arts in Law from University of Tokyo, Japan; Master of Business Administration from Kellogg School of Management, Northwestern University and is U.S. Certified Public Accountant.

WORK EXPERIENCE

Dr. Prem Kumar Nair was appointed Group Chief Executive Officer of IHH Healthcare on 1 October 2023, where he leads a team of more than 65,000 employees to realise IHH's vision to be the world's most trusted healthcare services network.

Dr. Nair sets the strategic direction for the sustainable growth of IHH's global network which today comprises more than 80 hospitals in 10 countries. Guided by its Care. For Good. aspiration, Dr. Nair continues to build on the IHH portfolio of strong and reputable brands including Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway - to touch lives and transform care globally.

Prior to his Group CEO appointment, he was CEO of IHH Singapore, where he oversaw the operations and management of IHH's business units in the country and played an instrumental role in its strategic business growth and outreach efforts in overseas markets.

Dr. Nair is a physician and healthcare executive with over three decades of experience in both public and private healthcare sectors. He was with Raffles Medical Group for 27 years, where he held concurrent roles as Chief Corporate Officer, and Managing Director for Singapore Healthcare. He is an Adjunct Associate Professor at the National University of Singapore's Saw Swee Hock School of Public Health.

An active community citizen, Dr. Nair was a recipient of the Public Service Medal (Pingat Bakti Masyarakat) and the Public Service Star (Bintang Bakti Masyarakat) at the 2010 and 2022 National Day Awards respectively, for his contributions to the Singapore Prison Service. He is also a Justice of the Peace.

Dr. Nair graduated from the National University of Singapore with a Bachelor of Medicine & Surgery, and a Master of Business Administration (Distinction) from Alliance Manchester Business School.

WORK EXPERIENCE

Dato' Sri Muthanna Abdullah is a Barrister of Middle Temple and an Advocate and Solicitor of the High Court of Malaya. He read law at the University of Buckingham, England and was called to the Bar of England and Wales in 1982 and to the Malaysian Bar in 1983. He is a Consultant of Abdullah Chan & Co.

Dato' Sri Muthanna was appointed as the Honorary Consul to Kuala Lumpur of the Republic of San Marino on 30 March 2017.

He is also a Director of IHH Healthcare Berhad, MSM Malaysia Holdings Berhad, MSIG Insurance Malaysia Berhad, Malaysian Life Reinsurance Group Berhad and Apollo Food Holdings Berhad.

WORK EXPERIENCE

As the Chief Executive Officer of IHH Singapore from 1 October 2023, Dr. Peter Chow oversees the operations and management of IHH's business units in Singapore, which includes Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East hospitals, primary healthcare group Parkway Shenton, Parkway MediCentre, as well as ancillary and education entities such as Parkway Radiology, Parkway Rehab, Parkway Cancer Centre and Parkway College.

Dr. Chow joined IHH in 2018 and was appointed as Chief Executive Officer of Mount Elizabeth Novena Hospital in 2020. Despite challenges from the Covid-19 pandemic, he led the hospital through a period of strategic development and growth, strengthening its position as a regional centre of clinical excellence. In 2022, he was awarded the Public Service Medal (Covid-19) for his healthcare leadership role during the pandemic and for supporting various national pandemic efforts in Singapore.

Dr. Chow has over 20 years of healthcare management experience spanning both public and private sectors in Singapore. Trained as a dental surgeon with the National University of Singapore, he started his career as a dental officer. Subsequently he took on different management roles including quality, training, manpower, as well as managed outpatient clinical services, giving him broad-based experience in healthcare.

Prior to IHH, he was with National Healthcare Group (NHG) during which he assumed various roles including Director of Quality & College, Director of Corporate Development & Communications and Chief Operating Officer of NHG Polyclinics.

WORK EXPERIENCE

Mr. Yong serves as the CEO and Executive Director of Parkway Trust Management Limited, the manager of PLife REIT.

He has led PLife REIT through a period of exceptional growth, cementing its position as a leading Asian healthcare REIT with total assets under management surpassing S$2.46 billion. Since assuming leadership, he has overseen a multi-fold expansion of the REIT's portfolio - from 3 to 75 properties - while delivering unitholder value through 136% cumulative growth in Distributions Per Unit and over 350% of Total Return, since its IPO.

Under his stewardship, PLife REIT's commitment to transparency, sustainability, and stakeholder engagement has been recognised with multiple awards, including the 2024 Shareholder Communications Excellence Award (SIAS Investors' Choice Awards) and the 2023 Singapore Corporate Sustainability Award for excellence in ESG practices and risk management. In 2022, PLife REIT was also named The Edge Singapore Billion Dollar Club Winner for delivering the highest returns to shareholders.

Mr. Yong's extensive expertise in finance and corporate strategy stems from his previous role as CFO of the Singapore Tourism Board, where he managed finance and corporate services. Before that, he served as CFO of Ascendas Pte Ltd, during which he was seconded to China-Singapore Suzhou Development Ltd and Singapore-Suzhou Township Development Pte Ltd as CFO in Suzhou, China. Prior to his role at Ascendas, Mr. Yong held various finance and audit positions at Beijing ISS International School, the Housing and Development Board, and Arthur Andersen.

A champion of sustainable growth, Mr. Yong's vision continues to drive PLife REIT's innovation in healthcare real estate, ensuring resilience and long-term value for stakeholders.